glucovance has been researched along with Coronary Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cadenas, J; Facta, AD; Hsueh, WA; Prior, JO; Quinones, MJ; Schelbert, HR; Schindler, TH | 1 |
| Adler, Y; Behar, S; Benderly, M; Boyko, V; Fisman, EZ; Friedensohn, A; Kohanovski, M; Motro, M; Rotzak, R; Schneider, H; Tenenbaum , A | 1 |
2 other study(ies) available for glucovance and Coronary Disease
| Article | Year |
|---|---|
Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes.
Topics: Blood Glucose; Blood Pressure; Case-Control Studies; Coronary Circulation; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburide; Heart Rate; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged | 2007 |
Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-up.
Topics: Administration, Oral; Coronary Disease; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Survival Analysis; Time Factors | 2001 |